These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31335153)

  • 41. An enteric polymer mitigates the effects of gastric pH on oral absorption of poorly soluble weak acid drugs from supersaturable formulations: A case study with dantrolene.
    Kataoka M; Nakanishi R; Umesaki M; Kobayashi M; Minami K; Higashino H; Yamaguchi S; Yamashita S
    Eur J Pharm Biopharm; 2020 Oct; 155():29-36. PubMed ID: 32771692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.
    Wagner C; Jantratid E; Kesisoglou F; Vertzoni M; Reppas C; B Dressman J
    Eur J Pharm Biopharm; 2012 Sep; 82(1):127-38. PubMed ID: 22652546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions.
    Hofmann M; García MA; Al-Gousous J; Ruiz-Picazo A; Thieringer F; Nguyen MA; Månsson W; Galle PR; Langguth P
    Eur J Pharm Biopharm; 2020 Apr; 149():229-237. PubMed ID: 32112894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate-CO
    Al-Gousous J; Sun KX; McNamara DP; Hens B; Salehi N; Langguth P; Bermejo M; Amidon GE; Amidon GL
    Mol Pharm; 2018 Nov; 15(11):5291-5301. PubMed ID: 30362350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
    Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a Unified Dissolution and Precipitation Model and Its Use for the Prediction of Oral Drug Absorption.
    Jakubiak P; Wagner B; Grimm HP; Petrig-Schaffland J; Schuler F; Alvarez-Sánchez R
    Mol Pharm; 2016 Feb; 13(2):586-98. PubMed ID: 26674605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study.
    Kennedy M; Hu J; Gao P; Li L; Ali-Reynolds A; Chal B; Gupta V; Ma C; Mahajan N; Akrami A; Surapaneni S
    Mol Pharm; 2008; 5(6):981-93. PubMed ID: 19434920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: Data in biorelevant media and in human aspirates.
    Litou C; Vertzoni M; Xu W; Kesisoglou F; Reppas C
    Eur J Pharm Biopharm; 2017 Jun; 115():94-101. PubMed ID: 28214603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context.
    Lennernäs H; Lindahl A; Van Peer A; Ollier C; Flanagan T; Lionberger R; Nordmark A; Yamashita S; Yu L; Amidon GL; Fischer V; Sjögren E; Zane P; McAllister M; Abrahamsson B
    Mol Pharm; 2017 Apr; 14(4):1307-1314. PubMed ID: 28195732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measuring pH and Buffer Capacity in Fluids Aspirated from the Fasted Upper Gastrointestinal Tract of Healthy Adults.
    Litou C; Psachoulias D; Vertzoni M; Dressman J; Reppas C
    Pharm Res; 2020 Jan; 37(3):42. PubMed ID: 31989335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of Hydroxypropyl Methylcellulose Acetate Succinate Critical Aggregation Concentration on Celecoxib Supersaturation.
    Bristol AN; Lamm MS; Li Y
    Mol Pharm; 2021 Dec; 18(12):4299-4309. PubMed ID: 34738825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
    Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media.
    Elkhabaz A; Sarkar S; Simpson GJ; Taylor LS
    Pharm Res; 2019 Oct; 36(12):174. PubMed ID: 31667638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu.
    Curatolo W; Nightingale JA; Herbig SM
    Pharm Res; 2009 Jun; 26(6):1419-31. PubMed ID: 19277850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids.
    Henze LJ; Koehl NJ; Jansen R; Holm R; Vertzoni M; Whitfield PD; Griffin BT
    Eur J Pharm Biopharm; 2020 Sep; 154():116-126. PubMed ID: 32580049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphate buffer interferes dissolution of prazosin hydrochloride in compendial dissolution testing.
    Sudaki H; Fujimoto K; Wada K; Sugano K
    Drug Metab Pharmacokinet; 2023 Aug; 51():100519. PubMed ID: 37393739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior.
    Kataoka M; Minami K; Takagi T; Amidon GE; Yamashita S
    Mol Pharm; 2021 Nov; 18(11):4122-4130. PubMed ID: 34618448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incorporation of HPMCAS during loading of glibenclamide onto mesoporous silica improves dissolution and inhibits precipitation.
    Price DJ; Nair A; Becker-Baldus J; Glaubitz C; Kuentz M; Dressman J; Saal C
    Eur J Pharm Sci; 2020 Jan; 141():105113. PubMed ID: 31655207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biphasic drug release testing coupled with diffusing wave spectroscopy for mechanistic understanding of solid dispersion performance.
    Jankovic S; O'Dwyer PJ; Box KJ; Imanidis G; Reppas C; Kuentz M
    Eur J Pharm Sci; 2019 Sep; 137():105001. PubMed ID: 31301486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption.
    Kaur N; Narang A; Bansal AK
    Eur J Pharm Biopharm; 2018 Aug; 129():222-246. PubMed ID: 29879527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.